Bridgebio Pharma Inc
(BBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -111,704 | -36,160 | -653,251 | -482,923 | -303,435 |
| Depreciation Amortization | 3,170 | 1,596 | 6,494 | 4,909 | 3,270 |
| Accounts receivable | 1,091 | -233,743 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 8,858 | -5,927 | 2,780 | -3,404 | -4,098 |
| Other Working Capital | 21,239 | -225,199 | 5,057 | -16,922 | -18,233 |
| Other Operating Activity | -67,488 | 279,896 | 111,200 | 95,439 | 64,821 |
| Operating Cash Flow | $-144,834 | $-219,537 | $-527,720 | $-402,901 | $-257,675 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -749 | -695 | -1,306 | -871 | -440 |
| Purchase Of Investment | -114,082 | -64,666 | -137,264 | -108,040 | -91,258 |
| Sale Of Investment | 118,229 | 63,229 | 193,106 | 163,513 | 108,618 |
| Purchase Sale Intangibles | -3,190 | -797 | N/A | N/A | N/A |
| Other Investing Activity | 22,394 | 24,885 | -503 | -503 | -503 |
| Investing Cash Flow | $25,792 | $22,753 | $54,033 | $54,099 | $16,417 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 450,000 | 450,000 | N/A | N/A | N/A |
| Debt Repayment | -473,417 | -473,417 | N/A | N/A | N/A |
| Common Stock Issued | 317,901 | 318,155 | 459,216 | 458,883 | 146,170 |
| Common Stock Repurchased | -4,679 | -2,936 | -6,880 | -4,325 | -1,715 |
| Dividend Paid | N/A | N/A | N/A | N/A | 4,563 |
| Other Financing Activity | -15,986 | -12,254 | -801 | 1,500 | 0 |
| Financing Cash Flow | $273,819 | $279,548 | $451,535 | $456,058 | $149,018 |
| Beginning Cash Position | 394,732 | 394,732 | 416,884 | 416,884 | 416,884 |
| End Cash Position | 549,509 | 477,496 | 394,732 | 524,140 | 324,644 |
| Net Cash Flow | $154,777 | $82,764 | $-22,152 | $107,256 | $-92,240 |
| Free Cash Flow | |||||
| Operating Cash Flow | -144,834 | -219,537 | -527,720 | -402,901 | -257,675 |
| Capital Expenditure | -749 | -695 | -1,306 | -871 | -440 |
| Free Cash Flow | -145,583 | -220,232 | -529,026 | -403,772 | -258,115 |